PHARMACEUTICAL AND LIFE SCIENCES
For manufacturers working under 21 CFR Part 211, EudraLex Volume 4 and the revised Schedule M of the Drugs Rules, 1945. The agents surface exceptions with evidence. Your reviewers and your Qualified Person decide.
Batch record review exceptions are the gaps between what an executed batch record says and what the rest of the quality landscape shows: an open deviation the record does not cite, an instrument past its calibration date, a packaging component on a superseded revision. The agents find these by reading every source and linking them to the batch.
THE COMPLIANCE LOAD
Batch record review as a queue.
Every executed record has to be reviewed before release, and the queue grows faster than the team.
Hybrid records.
Part of the record is electronic and part is paper, scanned, corrected and initialed by hand.
Deviations and investigations.
Open items in the quality system have to be reflected in the batches they affect.
Documentation per market.
The same product ships to markets with different specifications, artwork, serialization and release routes.
Supplier qualification.
Approvals lapse, and material keeps arriving.
Inspection readiness.
When an inspection is announced, the package has to exist on day one.
WHERE THE EVIDENCE LIVES
SYSTEM
WHAT IT HOLDS
ERP
Production orders, batch size, material receipts, supplier, market
Quality management system
Deviations, investigations, CAPA, change controls
Maintenance and calibration
Equipment status, calibration due dates
Laboratory system
Results, certificates of analysis, stability data
Document control
Specifications, methods, artwork and packaging instruction revisions
Serialization system
Identifiers generated and reported per market
Paper records (scanned)
Executed batch record pages, corrections, signatures
WHAT THE AGENTS DO HERE
USE CASE
ONE LINE
Batch record review
Every executed record assessed, exceptions surfaced with evidence
Documentation practice
Missing verification, corrections without initials, times not recorded, signature dates
Cross-system contradiction
The record says calibrated, the maintenance system says overdue
Deviation completeness
An open deviation in the quality system that the record does not cite
Market document applicability
Which specification, method, packaging instruction, artwork and release route apply to this batch and market
Artwork and labelling revision
Packing against a revision that was superseded before the packing date
Batch size against the approved range
A campaign batch outside the registered and validated range
Supplier approval validity
Material received after the approval lapsed
Serialization completeness
Identifiers generated and submitted as the market requires
Dated obligations
Licence renewals, change controls, release authority, announced inspections
Inspection package
What applied, which revisions were used, the evidence, the exceptions and their disposition
WORKED EXAMPLE
Illustrative. Fictional company, product and data.
Halvern Pharmaceuticals packs Tovarin 20 mg tablets, a prescription product, for an EU market. Pack order PO-24-0817 was packed in August. The carton carries the product name in Braille, a unique identifier and an anti-tampering device. In the EU, the outer packaging mock-up forms part of the marketing authorization, so the carton artwork is approved labelling.
What the agents read
1. ERP: pack order PO-24-0817, packing date in August, market EU.
2. Document control: carton artwork revision C, superseded in May by revision D.
3. Quality system: change control CC-24-112, which approved revision D in May.
4. Scanned batch record: the packing line clearance page lists artwork revision C.
Reasoning shown to the reviewer
1. Packing date is after the effective date of revision D.
2. The executed record cites revision C.
3. No deviation in the quality system references this pack order and revision C.
4. The carton is approved labelling for this market, so a superseded revision is a labelling exception, not only a document control gap.
What the agents found
The pack order was packed against artwork revision C after revision D became effective under change control CC-24-112.
What the reviewer sees
The finding, the four source items, the numbered reasoning, and three choices: confirm, reject with a reason, or request more evidence. Nothing is sent and nothing is recorded as an exception until the reviewer confirms.
What happens next
On confirmation, the agent drafts a follow-up to the packaging owner for approval and tracks the item until a disposition is recorded.
ONE GAP, SEVERAL AUTHORITIES
A site that supplies the United States, Europe, the United Kingdom and India answers to several frameworks. Many of their requirements describe the same control in different words. The agents map each open item to every framework that cites it, so your team can see which correction answers the most. Example: audit trail review that is not tied to each batch touches US FDA expectations, EU GMP Annex 11, MHRA data integrity guidance and the revised Schedule M.
REGULATIONS REFERENCED
21 CFR Part 211, current good manufacturing practice for finished pharmaceuticals
21 CFR Part 11, electronic records and electronic signatures
EudraLex Volume 4, Part I, and Annex 16, Qualified Person certification and batch release
Directive 2001/83/EC, Article 56a, Braille on outer packaging
Commission Delegated Regulation (EU) 2016/161, unique identifier and anti-tampering device
Drug Supply Chain Security Act, product identifier requirement at 21 USC 360eee-1(b)(2), definition at 21 USC 360eee(14)
Directive 2001/83/EC, Article 61, submission of outer packaging mock-ups
Drugs Rules, 1945 (formerly the Drugs and Cosmetics Rules), revised Schedule M notified 28 December 2023, and Rules 96 and 97 for labelling
ICH Q9(R1), quality risk management, and ICH Q10, pharmaceutical quality system
Release, certify or disposition a batch
Close a deviation, investigation or CAPA
File anything with an authority
Write to your systems outside the transitions you approve
Send a message without a named person's approval
Contact a regulatory authority or a customer
Promote itself to a higher autonomy level
Make you compliant. Compliance decisions and accountability stay with you.
QUALIFICATION
GOOD FIT
NOT A GOOD FIT
Solid oral, sterile or packaging operations with executed batch records
Expects the system to certify or release a batch
Multiple markets with different artwork and serialization rules
Wants the model, not a rule, to decide what is an exception
Records split between electronic systems and paper
Cannot name a reviewer for confirmed findings
QA teams preparing for announced or routine inspections
Looking for a replacement QMS or MES
Open to starting with an export for one product
Needs integration live before any evaluation
FAQ
Does this replace our QMS?
+
No. It reads the quality system alongside the rest of your landscape. Your systems of record do not change.
Can it read our scanned records?
+
Yes. Every extraction carries a confidence score, and anything below the threshold goes to a person.
Who releases the batch?
+
Your Qualified Person or release authority, exactly as today.
Send an export for one batch or lot and see the workspace run on your own data.
Which of your last ten batches would have passed review faster if the exceptions had arrived with their evidence attached?
